The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Vertex began researching ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less. Advertising Vertex began ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.